Märkte & Kurse

^ Original-Research: INDUS Holding AG - from NuWays AG 13.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions. --------------------------------------------------------------------------- Classification of NuWays AG to INDUS Holding AG Company Name: INDUS Holding AG ISIN: DE0006200108 Reason for the research: Update Recommendation: Buy from: 13.11.2024 Target price: EUR 34.00 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr Final Q3 results out // 2nd buyback offer announced; chg. est. Topic: INDUS released its final Q3 numbers in line with preliminary results. Even more importantly, the company announced a public buyback offer in the period from 12-25 November 2024 up to EUR 15.2m. To recap: Q3 sales decreased slightly by 3.6% to EUR 443m due to a challenging macro environment and low order backlog. Reported EBIT remained roughly unchanged yoy at a solid EUR 31.8m with a 7.2% EBIT margin. However, adjusted for impairments of EUR 6.7m in Q3'24 and EUR 17.6m in Q3'23, EBIT decreased by 22%. Personnel costs increased slightly by 0.6% yoy to EUR 129.4m despite a lower headcount (-1.6% yoy of continuing operations) due to a notable rise in wages and salaries. Cost of materials increased 1.4% yoy to EUR 195m with a 1.3pp increase in the cost ratio from a low comparable base. Order intake remained unchanged yoy at EUR 392m (EUR 391 in Q3'23) but on a low level due to a weak economic situation in the metal production and processing sectors. This leads to an order backlog of EUR 678m (vs. EUR 711m end of FY23). While the demand situation stopped declining and consolidated now on a low level (EUR 1,220m order intake 9M'24 vs. EUR 1,230m in 9M'23), the book to bill ratio is still slightly below 1.00 (0.95 in 9M'24). However, we estimate that INDUS has already overcome the low point, and we should see successive improvements for FY25e. Buyback offer announced: already in February, INDUS acquired 1.1m shares at a price of EUR 23 per share in a public buyback offer, amounting to 4.1% of its share capital, which are still held as treasury shares. The company announced now a second buyback offer at EUR 21.65 per share for 0.7m shares in the period from 12-25 November. In addition, INDUS intends to buy for up to EUR 5m, but no more than 0.2m shares on the open market between 2 December 2024 at the earliest and until 16 May 2025 at the latest. If both programs are conducted successfully, INDUS would hold up to 7.4% in treasury shares. According to management, shares from the second tender offer and the open market transaction will be cancelled. This is positive news, as the stock is clearly undervalued in our view and hence repurchasing shares offers an attractive return on invested capital compared to other capital allocation choices. Strong FCF: management confirmed the FCF outlook for FY24e of above EUR 110m. INDUS achieved EUR 71.9m FCF in 9M'24, EUR 34.2m lower than last year but still on a solid level. Further, FCF in 9M'23 includes a positive one-time effect of EUR 14.4m from a property sale. The FY target of EUR 110m looks plausible in our view (eNuW: EUR 115m), as working capital tends to come down in Q4 due to seasonal effects. With that, INDUS should deliver a strong FCFY'24e of c. 10%. 2025 outlook: According to management, the geopolitical and macroeconomic challenges should continue to exist in FY25e. However, compared to Q1'24, the situation has already visible improved. Thus, we expect to see a moderate top-line improvement for FY25e of 5.4% to EUR 1810m, of which EUR 40-50m should be contributed from M&A acquisitions in FY24e and FY25e as stated by management. Further, we expect EBIT to improve disproportionately to EUR 150m in FY25e (eNuW) due to less expected impairments and macroeconomic improvements. Nevertheless, INDUS has shown resilience even in an adverse business environment. On top of that, INDUS is trading at only 8x forward P/E (eNuW), offers an expected dividend yield of 5.8% (eNuW FY24e: EUR 1.2 per share), and delivers a strong FCFY24e of c. 10% (eNuW). Hence, we keep INDUS as one of NuWays' Alpha Picks and reiterate BUY with an unchanged PT of EUR 34, based on FCFY'24e. You can download the research here: http://www.more-ir.de/d/31299.pdf For additional information visit our website: www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++ --------------------------------------------------------------------------- The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com --------------------------------------------------------------------------- 2028595 13.11.2024 CET/CEST °